News | 2025.06.23
Oncovita, a spin-off from the Institut Pasteur, has been granted Orphan Drug Designation (ODD) status by the U.S. Food and Drug Administration (FDA) for its MVdeltaC cancer immunotherapy, designed to treat pleural mesothelioma, a rare cancer of the pleura often caused by asbestos.
Vidéo | 2025.06.25
Science and Music: When a doctoral student raps against tuberculosis! Our talented researcher Yaelle Wormser turns her passion for research into a powerful flow!In the fight against tuberculosis, our young scientists lack neither creativity nor determination.Original lyrics by Yaelle Wormser @Lady_PipetteMusic : Grind Mode - Nest BeatzMix & Master : Swann Camurat
Vidéo | 2025.06.25
The immune system doesn't just defend us: it regulates our metabolism, influences our behavior, helps repair tissue... and even plays a role during pregnancy.Yasmine Belkaid, Director General of the Institut Pasteur, looks back on the evolution of our understanding of the immune system, at the formal session of the Institut de France on June 3th, 2025. A fascinating vision of science, at the...
Vidéo | 2025.06.30
What if the great pandemics could die out naturally?That's what Javier Pizarro-Cerda, head of the Yersinia unit at the Institut Pasteur, has been studying by following the trail... of the plague!By analyzing the Yersinia pestis bacterium responsible for bubonic plague, his team has identified a genetic mutation that reappears at the end of every pandemic in history.This mutation makes the...
News | 2025.06.30
As part of the video series "My PhD at the Institut Pasteur," which highlights the work of the institute’s PhD students through short and accessible formats, a new episode features Yaëlle Wormser, a doctoral student in microbiology. Through a powerful rap, she raises public awareness about her research on tuberculosis, an infectious disease responsible for over 10 million cases and 1.25 million...
News | 2025.05.08
An avian influenza outbreak is currently circulating among birds, and sometimes also among farm mammals. What exactly do we know about this disease? What measures are being taken to contain it? What is the Institut Pasteur doing? Read on to find out more.
Vidéo | 2025.07.07
A race against time... to stay ahead of epidemics!Chloé Baum, an engineer at the Institut Pasteur, shows us how hand-held technology can identify viruses like Ebola in just a few hours.Thanks to genomic sequencing, researchers can read the DNA of viruses, spot their mutations and act before they spread. In French Guiana, New Caledonia or in laboratory trucks, the Pasteur Network tracks epidemics...
News | 2025.07.07
The Institut Pasteur is delighted that two of the winners of the new "Chairs of Excellence in Biology/Health" call for proposals round launched by the French National Research Agency (ANR) are its own scientists. Simonetta Gribaldo and Marc Lecuit were recognized for their innovative and ambitious projects in the biomedical research field.
Article | 2019.07.11
We live at a time when biology is producing vast reams of data, which can only be deciphered using mathematical modeling, statistics and computing, providing answers to a wide variety of biological and medical questions. The Department of Computational Biology was set up to analyze and model these data, and develop new analytical methods tailored to new data acquisition technologies (sequencing,...
Article | 2025.01.20
Exploring the genomes of bacteria, yeast, insect vectors and ultimately humans: that is the task of scientists in the Department of Genomes & Genetics. By investigating both simple and highly complex organisms, these scientists endeavor to shed new light on the nature of their genetic information.